EdgarLookup

uniQure N.V. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that uniQure N.V. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
-1518.1%
Profit Margin
Net income ÷ revenue
-24.1%
Return on Assets
Net income ÷ assets
3.15x
Debt-to-Equity
Total liabilities ÷ equity
-47.8%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $13.11M Mar 14, 2018
FY2017 Dec 31, 2016 $25.10M Mar 14, 2018
FY2017 Dec 31, 2015 $10.58M Mar 14, 2018
FY2016 Dec 31, 2014 $6.14M Mar 15, 2017

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($198.97M) Mar 2, 2026
FY2025 Dec 31, 2024 ($239.56M) Mar 2, 2026
FY2025 Dec 31, 2023 ($308.48M) Mar 2, 2026

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($185.35M) Mar 2, 2026
FY2025 Dec 31, 2024 ($184.29M) Mar 2, 2026
FY2025 Dec 31, 2023 ($282.87M) Mar 2, 2026
FY2024 Dec 31, 2022 ($143.16M) Feb 27, 2025
FY2023 Dec 31, 2021 $310.62M Feb 28, 2024
FY2022 Dec 31, 2020 ($125.43M) Feb 27, 2023
FY2021 Dec 31, 2019 ($121.14M) Feb 25, 2022
FY2020 Dec 31, 2018 ($88.23M) Mar 1, 2021
FY2019 Dec 31, 2017 ($71.34M) Mar 2, 2020
FY2018 Dec 31, 2016 ($71.95M) Feb 28, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $824.91M Mar 2, 2026
FY2025 Dec 31, 2024 $556.54M Mar 2, 2026
FY2024 Dec 31, 2023 $831.69M Feb 27, 2025
FY2023 Dec 31, 2022 $704.96M Feb 28, 2024
FY2022 Dec 31, 2021 $809.18M Feb 27, 2023
FY2021 Dec 31, 2020 $340.40M Feb 25, 2022
FY2020 Dec 31, 2019 $448.63M Mar 1, 2021
FY2019 Dec 31, 2018 $273.91M Mar 2, 2020
FY2018 Dec 31, 2017 $209.64M Feb 28, 2019
FY2017 Dec 31, 2016 $190.27M Mar 14, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $626.01M Mar 2, 2026
FY2025 Dec 31, 2024 $563.29M Mar 2, 2026
FY2024 Dec 31, 2023 $624.02M Feb 27, 2025
FY2023 Dec 31, 2022 $228.96M Feb 28, 2024
FY2022 Dec 31, 2021 $213.40M Feb 27, 2023
FY2021 Dec 31, 2020 $96.49M Feb 25, 2022
FY2020 Dec 31, 2019 $125.57M Mar 1, 2021
FY2019 Dec 31, 2018 $94.30M Mar 2, 2020
FY2018 Dec 31, 2017 $120.29M Feb 28, 2019
FY2017 Dec 31, 2016 $126.63M Mar 14, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $198.90M Mar 2, 2026
FY2025 Dec 31, 2024 ($6.75M) Mar 2, 2026
FY2025 Dec 31, 2023 $207.67M Mar 2, 2026
FY2025 Dec 31, 2022 $476.01M Mar 2, 2026
FY2024 Dec 31, 2021 $595.78M Feb 27, 2025
FY2023 Dec 31, 2020 $243.91M Feb 28, 2024
FY2022 Dec 31, 2019 $323.06M Feb 27, 2023
FY2021 Dec 31, 2018 $179.61M Feb 25, 2022
FY2020 Dec 31, 2017 $89.36M Mar 1, 2021
FY2019 Dec 31, 2016 $63.63M Mar 2, 2020

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 (3) Mar 2, 2026
FY2025 Dec 31, 2024 (4) Mar 2, 2026
FY2025 Dec 31, 2023 (6) Mar 2, 2026
FY2024 Dec 31, 2022 (2) Feb 27, 2025
FY2023 Dec 31, 2021 7 Feb 28, 2024
FY2022 Dec 31, 2020 (2) Feb 27, 2023
FY2021 Dec 31, 2019 (3) Feb 25, 2022

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 (3) Mar 2, 2026
FY2025 Dec 31, 2024 (4) Mar 2, 2026
FY2025 Dec 31, 2023 (6) Mar 2, 2026
FY2024 Dec 31, 2022 (2) Feb 27, 2025
FY2023 Dec 31, 2021 7 Feb 28, 2024
FY2022 Dec 31, 2020 (2) Feb 27, 2023
FY2021 Dec 31, 2019 (3) Feb 25, 2022

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $80.24M Mar 2, 2026
FY2025 Dec 31, 2024 $158.93M Mar 2, 2026
FY2025 Dec 31, 2023 $241.36M Mar 2, 2026
FY2024 Dec 31, 2022 $228.01M Feb 27, 2025
FY2023 Dec 31, 2021 $556.26M Feb 28, 2024
FY2022 Dec 31, 2020 $244.93M Feb 27, 2023
FY2021 Dec 31, 2019 $377.79M Feb 25, 2022
FY2020 Dec 31, 2018 $234.90M Mar 1, 2021
FY2019 Dec 31, 2017 $159.37M Mar 2, 2020
FY2018 Dec 31, 2016 $132.50M Feb 28, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $71.92M Mar 2, 2026
FY2024 Dec 31, 2024 $66.02M Feb 27, 2025
FY2023 Dec 31, 2023 $147.57M Feb 28, 2024
FY2022 Dec 31, 2022 $144.49M Feb 27, 2023
FY2021 Dec 31, 2021 $135.59M Feb 25, 2022
FY2020 Dec 31, 2020 $42.41M Mar 1, 2021
FY2019 Dec 31, 2019 $46.53M Mar 2, 2020
FY2018 Dec 31, 2018 $48.18M Feb 28, 2019
FY2017 Dec 31, 2017 $23.96M Mar 14, 2018